Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using multiple 'omics strategies for novel therapies in sepsis.

Literature DB >> 29546534

Using multiple 'omics strategies for novel therapies in sepsis.

James A Russell¹, Peter Spronk², Keith R Walley^3,2.

Abstract

Entities: Disease

Mesh：

Year: 2018 PMID： 29546534 DOI： 10.1007/s00134-018-5122-z

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

14 in total

1. Early antimicrobial therapy in severe sepsis and septic shock.

Authors: Anand Kumar
Journal: Curr Infect Dis Rep Date: 2010-09 Impact factor: 3.725

2. A shared frailty model for case-cohort samples: parent and offspring relations in an adoption study.

Authors: Liselotte Petersen; Thorkild I A Sørensen; Per Kragh Andersen
Journal: Stat Med Date: 2010-03-30 Impact factor: 2.373

3. Genetic and environmental influences on premature death in adult adoptees.

Authors: T I Sørensen; G G Nielsen; P K Andersen; T W Teasdale
Journal: N Engl J Med Date: 1988-03-24 Impact factor: 91.245

4. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors: Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuck Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal: Crit Care Med Date: 2017-03 Impact factor: 7.598

5. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

Authors: Evan A Stein; Scott Mellis; George D Yancopoulos; Neil Stahl; Douglas Logan; William B Smith; Eleanor Lisbon; Maria Gutierrez; Cheryle Webb; Richard Wu; Yunling Du; Therese Kranz; Evelyn Gasparino; Gary D Swergold
Journal: N Engl J Med Date: 2012-03-22 Impact factor: 91.245

6. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.

Authors: Christopher W Seymour; Foster Gesten; Hallie C Prescott; Marcus E Friedrich; Theodore J Iwashyna; Gary S Phillips; Stanley Lemeshow; Tiffany Osborn; Kathleen M Terry; Mitchell M Levy
Journal: N Engl J Med Date: 2017-05-21 Impact factor: 91.245

7. PCSK9 is a critical regulator of the innate immune response and septic shock outcome.

Authors: Keith R Walley; Katherine R Thain; James A Russell; Muredach P Reilly; Nuala J Meyer; Jane F Ferguson; Jason D Christie; Taka-aki Nakada; Chris D Fjell; Simone A Thair; Mihai S Cirstea; John H Boyd
Journal: Sci Transl Med Date: 2014-10-15 Impact factor: 17.956

8. Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia.

Authors: Eli M Roth; James M McKenney; Corinne Hanotin; Gaelle Asset; Evan A Stein
Journal: N Engl J Med Date: 2012-10-31 Impact factor: 91.245

9. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

Authors: Steven M Opal; Pierre-Francois Laterre; Bruno Francois; Steven P LaRosa; Derek C Angus; Jean-Paul Mira; Xavier Wittebole; Thierry Dugernier; Dominique Perrotin; Mark Tidswell; Luis Jauregui; Kenneth Krell; Jan Pachl; Takeshi Takahashi; Claus Peckelsen; Edward Cordasco; Chia-Sheng Chang; Sandra Oeyen; Naoki Aikawa; Tatsuya Maruyama; Roland Schein; Andre C Kalil; Marc Van Nuffelen; Melvyn Lynn; Daniel P Rossignol; Jogadish Gogate; Mary B Roberts; Janice L Wheeler; Jean-Louis Vincent
Journal: JAMA Date: 2013-03-20 Impact factor: 56.272

Review 10. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.

Authors: Marianne Abifadel; Jean-Pierre Rabès; Martine Devillers; Arnold Munnich; Danièle Erlich; Claudine Junien; Mathilde Varret; Catherine Boileau
Journal: Hum Mutat Date: 2009-04 Impact factor: 4.878

3 in total